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This Month in the Journal
When we think of complex traits, we often think of the
contribution of multiple genes and environmental fac-
tors to the phenotype. This month in the Journal, Sriram
et al. discuss a factor that may contribute to the com-
plexities of phenotypes associated with single-gene dis-
orders: moonlighting activities. Moonlighting enzymes
are metabolic enzymes with more than one unrelated
function. One can imagine that, when researchers are
blind to one or more functions of a moonlighting en-
zyme, there may be aspects of a phenotype that are not
explained by the main function of the protein. The au-
thors discuss known moonlighting activities as well as
methods for identifying additional moonlighting activi-
ties. As new functions are identified for some proteins,
it is likely that we will resolve some of the mysteries of
complex phenotypes related to those proteins, leaving
us better able to make genotype-phenotype correlations.
SNPs Responsible for a Linkage Signal, by Li et al. (p.
934)
Many research groups follow a similar procedure in their
attempts to identify a genetic locus: start with a genome
scan and follow that up with an association study in the
regions that showed linkage with the trait. But it can be
difficult to determine which associated markers are re-
sponsible for the linkage signal. To get around this prob-
lem, Li et al. developed a method that uses affected sib
pairs and jointly models linkage and association. This
allows them to determine whether a candidate SNP ac-
counts for the linkage to a region. Further, they can esti-
mate the amount of linkage disequilibrium between the
candidate SNP and the actual disease alleles to get an
idea of the degree to which a SNP accounts for the link-
age signal. Simulations indicate that their method has
good power to detect an association even when the sib-
ling recurrence risk is low.
OTX2 Mutations in Ocular Malformations, by Ragge
et al. (p. 1008)
Ragge et al. report the first OTX2 mutations associated
with ocular malformations. Their results stem from a
candidate-gene approach that included OTX2 because
of reports that the murine version of the gene is a key
regulator of photoreceptor-cell development and the
finding that deletions of the region surrounding OTX2
are sometimes observed in people with anophthalmia.
Of the 333 individuals with ocular malformations who
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were screened for OTX2 mutations, 8 had heterozygous
sequence changes in the coding region, although the sig-
nificance of two of these variants is not clear. Ocular
phenotypes ranged from borderline microphthalmia to
bilateral anophthalmia, and some individuals also had
severe learning disabilities and seizures. Reduced pene-
trance, parental mosaicism, and phenotypic variability
appear to be commonly associated with these mutations
and may make genetic counseling of affected families
less than straightforward. In contrast with the cranio-
facial malformations reported in heterozygous Otx2
knockout mice, there was an absence of craniofacial
abnormalities in the study individuals, although the au-
thors point out that this could have been due to the
sample ascertainment. In conjunction with expression
studies, these mutations give greater insight into the role
of OTX2 in ocular development.
FOXP2 Truncation Impairs Speech and Language, by
MacDermot et al. (p. 1074)
In 2001, Lai et al. (see references in MacDermot et al.)
reported a family with a missense mutation in FOXP2
and a proband with a translocation disrupting the same
gene; both mutations were associated with a severe speech
and language disorder. The report of Lai et al. generated
a lot of interest in FOXP2, and subsequent studies were
designed to look for mutations in individuals with such
language-related phenotypes as autism, dyslexia, and
speech-language impairment. Despite these efforts, the
missense mutation in the original family is the only un-
equivocal FOXP2 mutation that has been found. Mac-
Dermot et al. reasoned that their chances of finding ad-
ditional FOXP2 mutations would increase if they fo-
cused on individuals with a phenotype similar to the
cases in the original report. The hallmark of this phe-
notype was verbal dyspraxia, which is a deficit in the
coordination of the orofacial movements required for
speech. They screened FOXP2 in 49 probands with dif-
ficulties in speech articulation but no mental retardation,
congenital abnormalities, or hearing problems, and they
report a nonsense mutation that segregates with the phe-
notype and results in functional, if not actual, FOXP2
haploinsufficiency. Two other coding changes in FOXP2
were identified but were not present in affected siblings
of the probands and are therefore of uncertain signifi-
cance. A preliminary characterization of the phenotype
in the family with the nonsense mutation suggests that
the language defects are similar to those reported in the
earlier FOXP2-associated family. Comparisons of these
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families may yield further insight into the role of FOXP2
in neurological and cognitive development.
SUCLA2 Mutation in mtDNA Depletion, by Elpeleg et
al. (p. 1081)
While we’re talking about moonlighting proteins (see
the review article in this issue), it might be interesting
to mention that Elpeleg et al. report a somewhat unex-
pected mutation associated with encephalomyopathy and
mtDNA depletion. It was found in a family with severely
retarded psychomotor development, muscle hypotonia,
impaired hearing, and seizures. The activities of oxi-
dative phosphorylation complexes containing mtDNA-
encoded proteins were decreased in the affected individ-
uals, which was consistent with the 50% reduction in
the mtDNA-nuclear ratio in these kids. Homozygosity
mapping localized the critical region to chromosome 13,
and predictions for mitochondrial localization based on
the ORFs in this region were used to prioritize the can-
didates therein. The affected individuals all had a re-
arrangement in SUCLA2, a gene encoding part of the
ADP-forming succinyl-CoA synthetase (SCS-A), which
plays a role in the tricarboxylic acid cycle. So what does
this have to do with mtDNA levels? It turns out that
SCS-A is tightly associated with a nucleoside diphos-
phate kinase (NDPK) that is critical for maintaining ho-
meostasis of deoxyribonucleotides. Although the signifi-
cance of this association is not clear, it appears that
SCS-A disruption might alter NDPK function and lead
to mtDNA depletion. Although a true moonlighting ac-
tivity for SCS-A hasn’t yet been demonstrated, these re-
sults point to a secondary and unexpected role for the
protein.
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